Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00486668
Status:
UNKNOWN
Last Update Posted:
2016-06-06
First Post:
2007-06-13
Brief Title:
A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
Sponsor:
NSABP Foundation Inc
Organization:
NSABP Foundation Inc
Organization Data
Organization:
NSABP Foundation Inc
Class:
NETWORK
Study ID:
NSABP B-41
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NSABP Foundation Inc
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |